Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

Carmoxirole - reducing amisulpride's side effects

Posted by ed_uk on May 3, 2006, at 13:09:59

Sulpiride (Dolmatil) and amisulpride (Solian) are antipsychotics which are used in the treatment of schizophrenia. Although these drugs cause less EPS than typical APs, hyperprolactinemia is still a common problem, leading to numerous unpleasant side effects eg. sexual dysfunction, lactation etc.

Carmoxirole is a peripherally-acting dopamine agonist, it does not cross the blood brain barrier in significant quantities. In theory, carmoxirole could reverse amisulpride-induced hyperprolactinemia without affecting antipsychotic efficacy.

Eur J Pharmacol. 2002 Jun 28;447(1):109-14.

Carmoxirole is able to reduce amisulpride-induced hyperprolactinemia without affecting its central effect.

Marchese G, Ruiu S, Casti P, Bartholini F, Saba P, Gessa GL, Pani L.

Neuroscienze S.c.a.r.l., Cagliari, Italy.

Prolactin blood level and apomorphine-induced yawning were studied in rats treated with the substituted benzamide amisulpride in association with bromocriptine or carmoxirole; two dopamine D(2) receptor agonists with high or low propensity to cross the brain-blood barrier, respectively. Administration of amisulpride produced a maximum increase in rat serum prolactin level (315+/-18%) vs. vehicle-treated animals (ED(50)=0.25+/-0.017 mg/kg, s.c.). The concurrent administration of carmoxirole or bromocriptine completely reversed the hyperprolactinemia induced by amisulpride (0.5 mg/kg, s.c.) (ID(50)=14.9+/-0.8 mg/kg and 0.81+/-0.03 mg/kg, respectively). Carmoxirole (15 mg/kg, i.p.) did not affect yawning induced by apomorphine (0.08 mg/kg, s.c.) nor amisulpride (0.5 mg/kg, s.c.) blockade of apomorphine-induced yawning. Conversely, a significant increase in the number of yawns was observed when bromocriptine (0.8 mg/kg, i.p.) was associated with apomorphine in the absence or presence of amisulpride. These results suggested that a peripheral dopamine D(2) receptor agonists could be a useful tool in alleviating amisulpride-induced hyperprolactinemia without possibly affecting its central effect.

.........................................unfortunately, carmoxirole is not available as a medication.

Ed


Share
Tweet  

Thread

 

Post a new follow-up

Your message only Include above post


Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.

 

Start a new thread

 
Google
dr-bob.org www
Search options and examples
[amazon] for
in

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:ed_uk thread:639622
URL: http://www.dr-bob.org/babble/20060429/msgs/639622.html